Clinical Research Directory

Inclusion Criteria: 1. Signed written informed consent； 2. Age ≥18； 3. Patients with confirmed or suspected clear cell renal cell carcinoma; 4. Expected survival ≥6 months. Exclusion Criteria: 1. Renal mass is known to be a metastasis of another primary tumor; 2. Have other malignancies that require treatment; 3. Have received chemotherapy, radiotherapy, or immunotherapy within 4 weeks; 4. Renal insufficiency with glomerular filtration rate (GFR) ≤ 60 mL/min/1.73 m²; 5. Pregnant and lactating women or female patients plan to become pregnant within 6 months; 6. Uncontrolled psychiatric disorders; 7. Vulnerable population (e.g., being in detention) or have a serious non-malignant disease (e.g., infectious disease, autoimmune disease, or metabolic disease).